Item 8.01 Other Events.
Beginning onJanuary 9, 2023 ,Senti Biosciences, Inc. (the "Company") will participate in the 41st AnnualJ.P. Morgan Healthcare Conference with investors. A copy of the Company's presentation materials has been posted to the Company's website and is filed herewith as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.
Cautionary Statement
This filing and the exhibits include "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act, and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies, and prospects, which are based on the information currently available to us and on assumptions we have made. Important factors that may cause actual results to differ materially from those described in the forward-looking statements are disclosed in the respective exhibits and in the "Risk Factors" contained in the Company's Form 10-Q filed with theSecurities and Exchange Commission (the "Commission") onNovember 10, 2022 , and other filings we make with the Commission. All forward-looking statements are expressly qualified in their entirety by such factors. We do not undertake any duty to update any forward-looking statement except as required by law.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1 Corporate presentation. 104 Cover Page Interactive Data File (embedded
within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source